Equillium (EQ) Depreciation and Depletion (2023 - 2026)
Equillium (EQ) posted quarterly Depreciation and Depletion of $24000.0 for Q1 2026, down 27.27% year-over-year from $33000.0 in Q1 2025, and up 242.86% quarter-over-quarter from $7000.0 in Q4 2025.
Equillium (EQ) Depreciation and Depletion (2023 - 2026) Analysis & Trends
Equillium (EQ) has reported Depreciation and Depletion for 4 consecutive years, with $24000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Depreciation and Depletion fell 27.27% year-over-year to $24000.0; the TTM figure through Mar 2026 stood at $91000.0 (down 9.9% YoY), while the FY2025 annual figure was $100000.0, changed 0.0% from the prior year.
- Depreciation and Depletion grew to $24000.0 in Q1 2026 per EQ's latest filing, from $7000.0 in the prior quarter.
- Across five years, Depreciation and Depletion topped out at $35000.0 in Q2 2024 and bottomed at -$2000.0 in Q4 2024.
- Historically, Depreciation and Depletion has averaged $26923.1 across 4 years, with a median of $31000.0 in 2023.
- Annual changes were most pronounced in 2024 — Depreciation and Depletion plunged 106.06% — and 2025, when it surged 450.0%.
- Equillium's Depreciation and Depletion stood at $33000.0 in 2023, then slumped by 106.06% to -$2000.0 in 2024, then soared by 450.0% to $7000.0 in 2025, then jumped by 242.86% to $24000.0 in 2026.
- Business Quant data shows EQ's Depreciation and Depletion at $24000.0 in Q1 2026, $7000.0 in Q4 2025, and $28000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation and Depletion (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 2.10 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 38.91 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 3.18 Mn |
| 10 | Equillium | 263.86 Mn | 263.86 Mn | - | 26,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 26,000.00 |
| Jun 30, 2026 | 26,000.00 |
| Mar 31, 2026 | 24,000.00 |
| Mar 31, 2026 | 24,000.00 |
| Dec 31, 2025 | 7,000.00 |
| Dec 31, 2025 | 7,000.00 |
| Sep 30, 2025 | 28,000.00 |
| Sep 30, 2025 | 28,000.00 |
| Jun 30, 2025 | 32,000.00 |
| Jun 30, 2025 | 32,000.00 |
| Mar 31, 2025 | 33,000.00 |
| Mar 31, 2025 | 33,000.00 |
| Dec 31, 2024 | -2,000.00 |
| Dec 31, 2024 | -2,000.00 |
| Sep 30, 2024 | 35,000.00 |
| Sep 30, 2024 | 35,000.00 |
| Jun 30, 2024 | 35,000.00 |
| Jun 30, 2024 | 35,000.00 |
| Mar 31, 2024 | 32,000.00 |
| Mar 31, 2024 | 32,000.00 |